1Allies L E,Grehard B,Hogge D E. Detection and characterization of primitive maligant and normal progenitors in patiems wotj acute myelogenous leukemia using long term coculture with supportive feeder layer and cytokines [J]. Blood 1997. 90, 2555- 2564.
2Blair A, Hogye D E, Sutherland H J. Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the pheootype CD54^+/CD71^-/HLA-DR-[ J ]. Blood,1998,92 : 4325 - 4335.
3Lapodot T.Sirard C, Vormoor J ,et al. A cell initiating human acute myeloid leukemia after transplantation into SCID micel[J]. Nature, 1994,8: 645- 647.
4Ailles L E, Gerhard B, Kawagoe H, et al. Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in non bese diabetic/severe combined immunodeficiem mice[J]. Blood, 1999. 94:1761-1772.
5Blair A,Sutherland H J. Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack expression of C-kit (CD117)[J]. Exv Hematol, 2000,28 : 660- 671.
6Guan Y,Gerhard B,Hogge D E. Detection,isolation,and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia(AML) [J]. Blood, 2003,101 :3142-3149.
7Blair A, Hogge D E.Ailler L E, et al.Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with longterm proliferative ability in vitro and in vivo[J]. Blood, 1997.89 ,3104- 3111.
8Jordan C T,Upchureh D,Szilvassy S J, et al. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cell [J]. Leukemia, 2000,14 : 1777- 1784.
9Yao M, Bounet S, Haruois C, et al. Quantitative and qualitative aherations of long-term culture-initiating cells in patients with acute leukeaemia in complete remission [J]. Br J Haemalol, 1998, 103,124- 128.
10Herman P H. Van Bockstaele D R. Ferraut A,et al. In vitro evaluation of the haemopoietie defect of CD34^+ cells from patients with acute myeloid leukemia in first remission[J]. Br J Haematol, 1999,106 : 142- 151.
2Bain BJ.Di Guglielmo and his syndromes.Br J Haematol,2003;120,939-943
3Bennett JM,Catovsky D,Daniel MT,et al.Proposals for the classification of the acute leukemias.Br J Haematol,1976; 33:451 -458
4Bennett JM,Catovsky D,Daniel MT,et al.Proposals for the classification of the myelodysplastic syndromes.Br J Haematol,1982;51:189-199
5Bennett JM,Catovsky D,Daniel MT,et al.Proposed revised criteria for the classification of acute myeloid leukemia.A report of the French-American-British Cooperative Group.Ann Intern Med,1985; 103:626-629
6Brunning RD,Bennett J,Matutes E,et al.Acute myeloid leukaemias not otherwise categorized.WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues.Lyon:IARC Press,2001:97-99
7Kowal-Vern A,Mazzella FM,Cotelingam JD,et al.Diagnosis and characterization of acute erythroleukemia subsets by determining the percentages of myelobalsts and proerythroblasts in 69 cases.Am J Hematol,2000; 65:5-13
8Lichtman MA.Classification and clinical manifestations of the clonal myeloid disorders.in Williams Hematblogy.McGraw-Hill.6th ed,2001:1019-1027
9Roggli VL,Subach J,Saleem A.Prognostic factors and treatment effects on survival in erythroleukemia:a retrospective study of 134 cases.Cancer,1981; 48:1101 -1105
10Roggli VL,Saleem A.Erythroleukemia:a study of 15 cases and literature review.Cancer,1982; 49:101-108
